Literature DB >> 28761435

Critical signaling pathways during Wallerian degeneration of peripheral nerve.

Qiong Cheng1, Ya-Xian Wang1, Jun Yu1, Sheng Yi1.   

Abstract

Wallerian degeneration is a critical biological process that occurs in distal nerve stumps after nerve injury. To systematically investigate molecular changes underlying Wallerian degeneration, we used a rat sciatic nerve transection model to examine microarray analysis outcomes and investigate significantly involved Kyoto Enrichment of Genes and Genomes (KEGG) pathways in injured distal nerve stumps at 0, 0.5, 1, 6, 12, and 24 hours, 4 days, 1, 2, 3, and 4 weeks after peripheral nerve injury. Bioinformatic analysis showed that only one KEGG pathway (cytokine-cytokine receptor interaction) was significantly enriched at an early time point (1 hour post-sciatic nerve transection). At later time points, the number of enriched KEGG pathways initially increased and then decreased. Three KEGG pathways were studied in further detail: cytokine-cytokine receptor interaction, neuroactive ligand-receptor interaction, and axon guidance. Moreover, temporal expression patterns of representative differentially expressed genes in these KEGG pathways were validated by real time-polymerase chain reaction. Taken together, the above three signaling pathways are important after sciatic nerve injury, and may increase our understanding of the molecular mechanisms underlying Wallerian degeneration.

Entities:  

Keywords:  Kyoto Enrichment of Genes and Genomes; Wallerian degeneration; axon guidance; bioinformatic analysis; cytokine-cytokine receptor interaction; microarray; nerve regeneration; neural regeneration; neuroactive ligand-receptor interaction; peripheral nerve regeneration; sciatic nerve transection; signaling pathway

Year:  2017        PMID: 28761435      PMCID: PMC5514877          DOI: 10.4103/1673-5374.208596

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


Introduction

Wallerian degeneration is an important degenerative process that occurs in distal nerve stumps in response to nerve fiber injury (Coleman, 2005; Coleman and Freeman, 2010). It occurs in both the central nervous system and peripheral nervous system, although it normally occurs within 1 to 2 weeks after injury in the peripheral nervous system but does not occur until a few months or even years after injury to the central nervous system (Griffin et al., 1992; George and Griffin, 1994). Timely occurrence of Wallerian degeneration in the peripheral nervous system may contribute to axonal regeneration due to clearance of myelin debris and growth inhibitors, and subsequent establishment of a regenerative microenvironment (Avellino et al., 1995; Vargas and Barres, 2007). However, delayed Wallerian degeneration in the central nervous system may hinder axonal regeneration. Accordingly, it is believed that Wallerian degeneration plays a key role in nerve regeneration (Lunn et al., 1989; Brown et al., 1991, 1992). Considering the importance of Wallerian degeneration, numerous studies have been performed to identify underlying biological changes. These studies show that macrophages, monocytes, and Schwann cells work together to remove axon and myelin debris, and clear a path for subsequent axonal regrowth and nerve regeneration (Geuna et al., 2009; Sta et al., 2014). These morphological and genetic studies have identified many central factors, including nicotinamide mononucleotide adenylyltransferase 2 (Coleman and Freeman, 2010; Gilley and Coleman, 2010; Gilley et al., 2013). Furthermore, emerging high-throughput studies have been performed to decipher global molecular changes. For example, in our previous study, we jointly re-annotated and re-analyzed microarray data (Yao et al., 2012, 2013) using bioinformatic tools including Euclidean distance calculation, hierarchical clustering, principle component analysis, gene ontology analysis, Kyoto Enrichment of Genes and Genomes (KEGG) analysis, and Ingenuity Pathway Analysis. Altogether, we obtained an integrated global view of genetic changes in injured distal nerve stumps (Yu et al., 2016; Yi et al., 2017). In particular, KEGG analysis outcomes identified pathways with P-values less than 0.05, indicating they may play critical roles in Wallerian degeneration (Yi et al., 2017). Taking the importance of signaling pathways into account, in the current study, we examined in detail these significantly enriched pathways in distal nerve stumps at various time points following sciatic nerve transection. Our aim was to achieve greater insight into dynamic molecular changes underlying Wallerian degeneration and identify critical biological processes for treatment of peripheral nerve repair and regeneration.

Materials and Methods

Rat sciatic nerve transection

A total of 66 adult, 2-month-old, male Sprague-Dawley rats weighing 180 to 220 g were obtained from the Experimental Animal Center, Nantong University, China (animal license No. SCXK [Su] 2014-0001 and SYXK [Su] 2012-0031). All animal surgery procedures were performed in accordance with Institutional Animal Care guidelines of Nantong University, and ethically approved by the Administration Committee of Experimental Animals, Jiangsu Province, China (No. 20160229-007). The experiment followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978), and “Consensus Author Guidelines on Animal Ethics and Welfare” by the International Association for Veterinary Editors (IAVE). Rat sciatic nerve transection was performed, as previously described (Yu et al., 2016; Yi et al., 2017). Briefly, Sprague-Dawley rats were equally and randomly divided into eleven groups with 6 rats in each group. Following anesthetization, rat hair was shaved and the surgical area cleansed with 75% ethanol. An incision was made on the lateral aspect of the mid-thigh of the rat left hind limb, the sciatic nerve was lifted, and a 10-mm long segment was removed from the middle of the femur. At 0.5, 1, 6, 12, and 24 hours, 4 days, and 1, 2, 3, and 4 weeks post-sciatic nerve transection, rats were sacrificed by decapitation and distal nerve stumps were collected. Sham-operated rats (rats with sciatic nerves exposed but uninjured) were used as controls and designated as 0 hour post-sciatic nerve transection.

RNA extraction and microarray analysis

RNA samples were extracted from distal nerve stumps using Trizol reagent (Life Technology, Carlsbad, CA, USA). Remaining DNA was removed using RNeasy spin columns (Qiagen, Valencia, CA, USA). Purified RNA samples were then quantified using a NanoDrop ND-1000 spectrophotometer (Infinigen Biotechnology Inc., City of Industry, CA, USA). Microarray analysis was performed in accordance with previous studies (Yao et al., 2012, 2013). Briefly, an Affymetrix GeneChip Oven 640 and Gene Array Scanner 3000 (Affymetrix, Santa Clara, CA, USA) were used to obtain microarray outcomes. These outcomes were then analyzed by the R software platform (v.2.13.0) and limma (linear regression model) package (Ritchie et al., 2015).

Bioinformatic analysis

Expression levels of mRNAs at 0.5, 1, 6, 12, and 24 hours, 4 days, and 1, 2, 3, and 4 weeks post-sciatic nerve transection were compared with those at 0 hour post-nerve transection. Genes with fold changes > 2 or < −2 (absolute value of log2 fold change > 1) and adjusted P-values < 0.05 were considered to be differentially expressed. Differentially expressed genes were then systematically analyzed using Database for Annotation, Visualization, and Integrated Discovery to enrich significant involved KEGG pathways.

Quantitative real time-polymerase chain reaction

RNA samples (0.5 μg) were reverse transcribed to cDNA using the Prime-Script Reagent Kit (TaKaRa, Dalian, China) for subsequent amplification. Quantitative real time-polymerase chain reaction (RT-PCR) was then performed using SYBR Green Premix Ex Taq (TaKaRa) with specific primer pairs on an Applied Biosystems Stepone real-time PCR System (Applied Biosystems, Foster City, CA, USA). Primer pair sequences were: Eph receptor A4 (Epha4), (forward) 5’-CGC CGT AGT ATC AGT GGG TG-3’ and (reverse) 5’-GTC TGT TCG GTA CTG GCT CA-3’; met proto-oncogene (Met), (forward) 5’-CGC TGC AGG CTG TGG ATT TA-3’ and (reverse) 5’-GGT GAA ATG TGC TGT GCG AG-3’; interleukin 11 (Il11), (forward) 5’-CCG ACT GGA ACG GCT ACT TC-3’ and (reverse) 5’-GAC GAT GTC GAT GGT GGC TT-3’; prostaglandin E receptor 2 (Ptger2), (forward) 5’-TTC TAT GGC GGA GAC GG-3’ and (reverse) 5’-GGT CCC ACT TTT CCT TTC GGG-3’; and glyceraldehyde 3-phosphate dehydrogenase (Gapdh), (forward) 5’-CCT TCA TTG ACC TCA ACT ACA TG-3’ and (reverse) 5’-CTT CTC CAT GGT GAA GAC-3’. Ct values were obtained for mRNA quantification using the ΔΔCt method and Gapdh as the reference gene.

Statistical analysis

Data were presented as the mean ± SEM. Differences between groups were tested by one-way analysis of variance using GraphPad Prism 6.0 (GraphPad Software, Inc., San Diego, CA, USA). P-values < 0.05 were considered statistically significant.

Results

Overview of significantly involved KEGG pathways during Wallerian degeneration

Our previous study showed that many KEGG pathways are significantly involved in Wallerian degeneration (Yi et al., 2017). To further study these activated KEGG pathways, we analyzed enriched KEGG pathways at various time points post-sciatic nerve transection. KEGG pathways with P-values less than 0.05 are listed in . List of significantly involved Kyoto Enrichment of Genes and Genomes at various time points during Wallerian degeneration identified by bioinformatic analysis At 0.5 hour post-sciatic nerve transection, no KEGG pathway was significantly involved. At 1 hour post-nerve transection, only one KEGG pathway, cytokine-cytokine receptor interaction was significantly activated. At 6 hours post-nerve transection, hematopoietic cell lineage, neuroactive ligand-receptor interaction, Jak-STAT signaling pathway, and mitogen-activated protein kinases signaling pathway were also activated. At 12 hours post-nerve transection, more KEGG pathways were involved including those involved in cancer, calcium signaling pathway, axon guidance, insulin signaling pathway, and Prion diseases. At later time points, the number of significantly involved KEGG pathways decreased. Some of the above-mentioned pathways (e.g., neuroactive ligand-receptor interaction) remained highly activated. Some novel KEGG pathways emerged at longer time points post-nerve transection, such as cell adhesion molecules (CAMs) and tight junctions.

Cytokine-cytokine receptor interaction

Cytokine-cytokine receptor interaction (rno04060) was the only KEGG pathway activated immediately post-sciatic nerve transection, and strongly activated thereafter at early stages (1, 6, and 12 hours) following nerve transection. A schematic network of the cytokine-cytokine receptor interaction was built based on the KEGG Orthology Database (http://www.genome.jp/kegg/ko.html), with differentially expressed genes labeled (). Many chemokines, cytokines, and their corresponding receptors, including C-X-C motif chemokine ligand 2 (Cxcl2), interleukin 6 (Il6), interleukin-11 (Il11), colony stimulating factor 3 receptor (Csf3r), colony stimulating factor 2 (Csf2), MET proto-oncogene, receptor tyrosine kinase (Met), interferon A (Ifna), interleukin 1A (Il1a), and interleukin 1R2 (Il1r2) were significantly up-regulated in injured distal nerve stumps. Only one gene, kinase insert domain receptor (Kdr), a gene that encodes vascular endothelial growth factor receptor, was down-regulated post-sciatic nerve transection. Significant differentially expressed genes in cytokine-cytokine receptor interaction

Neuroactive ligand-receptor interaction

Neuroactive ligand-receptor interaction (rno04080) was another KEGG pathway activated at a relatively early time point (6 hours post-sciatic nerve transection). Further, this KEGG pathway was activated at all time points from 6 hours to 4 weeks post-nerve transection, suggesting that it is critical for Wallerian degeneration and subsequent nerve regeneration. Receptors of numerous neurotransmitters and mediators, such as histamine receptor (Htr), prostaglandin E2 receptor 1 (Ptger), adenosine receptor (Adora), and leukotriene B4 receptor (Ltb4r) were up-regulated. In contrast, dopamine receptor (Drd), neurotensin receptor (Ntsr), MAS proto-oncogene or mas-related G-protein coupled receptor A (Mas1), cysteinyl-leukotriene receptor (Cysltr), corticotropin-releasing hormone receptor (Crhr), metabotropic glutamate receptor (Grm), purinergic receptor P2X (P2rx), and leptin receptor (Lepr) were down-regulated (). Significant differentially expressed genes in neuroactive ligand-receptor interaction

Axon guidance

Besides cytokine-cytokine receptor interaction and neuroactive ligand-receptor interaction, two KEGG pathways significantly enriched at various time points during Wallerian degeneration, axon guidance signaling pathway (rno04360) was a KEGG pathway activated at 12 hours post-nerve transection, and also studied in detail based on its importance for successful nerve regeneration and functional reconstruction. Accordingly, Met, a previously identified activated gene in the cytokine-cytokine receptor interaction pathway, was also involved in the axon guidance pathway. In addition, the ephrin receptor, Epha, was also up-regulated while the netrin receptor, Unc-5, was down-regulated (). Significant differentially expressed genes in axon guidance signaling. Up-regulated genes are labeled in red, while down-regulated genes are labeled in green. The figure was modified based on Kyoto Enrichment of Genes and Genomes Orthology Database (rno04360). Fyn: fyn proto-oncogene; Cdk5: cyclin dependent kinase 5; Crmp: collapsing response mediator protein; Cram: dihydropyrimidinase like 5; Nrp1: neuropilin 1; Fes: feline sarcoma oncogene; Rac: Rac protein; Pak: p21-activated kinase; Limk: LIM domain kinase; Met: met proto-oncogene; Larg: rho guanine nucleotide exchange factor 12; Rhoa: ras homolog family member A; Itgb1: integrin subunit beta 1; Erk: extracellular regulated MAP kinase; Dcc: deleted in colorectal carcinoma netrin 1 receptor; Nck1: non-catalytic region of tyrosine kinase adaptor protein 1; Ablim: actin binding LIM protein; Caln: protein phosphatase 3 catalytic subunit alpha; Nfat: nuclear factor of activated T-cells; Rock: rho kinase; Ngl-1/2: netrin-G1 ligand 1/2; Unc-5: netrin receptor unc-5; Epha: Eph receptor A; Cdc42: cell division cycle 42; Abl: Abelson murine leukemia viral oncogene homolog; Rasgap: RAS p21 protein activator 1; Ephb: Eph receptor B; Robo1/2: roundabout homolog 1/2; srgap: SLIT-ROBO rho GTPase activating protein.

RT-PCR verification of microarray results

RT-PCR experiments were performed to validate temporal expression patterns of representative differentially expressed genes involved in the KEGG pathways: cytokine-cytokine receptor interaction (Il11), neuroactive ligand-receptor interaction (Ptger), and axon guidance (Epha and Met). Consistent with our microarray analysis outcomes, RT-PCR confirmed that Epha4, Met, Il11, and Ptger2 expression levels were robustly increased, especially at longer time points post-sciatic nerve transection (). Quantitative real time-polymerase chain reaction for mRNA expression of Epha4 (A), Met (B), Il11 (C), and Ptger2 (D). Relative levels were normalized to Gapdh. Summarized data are from three independent experiments. Values are shown as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, vs. 0 hour (one-way analysis of variance). Epha4: Eph receptor A4; Met: met proto-oncogene; Il11: interleukin 11; Ptger2: prostaglandin E receptor 2; Gapdh: glyceraldehyde 3-phosphate dehydrogenase; h: hour(s); d: days; w: week(s).

Discussion

Wallerian degeneration helps form a penetrable pathway for axon regrowth, and consequently, is very important for subsequent nerve repair and regeneration (Bittner et al., 2016). Until now, many critical factors for Wallerian degeneration have been identified. However, Wallerian degeneration is a complex biological process mediated by a group of molecules instead of a single gene or protein. Thus, obtaining a global view of molecular changes during Wallerian degeneration is of utmost importance. Accordingly here, by combined use of microarray and bioinformatic analysis, we synthetically analyzed highly activated KEGG signaling pathways (cytokine-cytokine receptor interaction, neuroactive ligand-receptor interaction, and axon guidance signaling pathway) following sciatic nerve transection. Consistent with previous observations (Li et al., 2013, 2014; Yao et al., 2013; Yi et al., 2017), the KEGG pathway, cytokine-cytokine receptor interaction, was significantly involved from an early stage post-sciatic nerve injury. Detailed study of the cytokine-cytokine receptor interaction KEGG pathway suggests that most differentially expressed genes are related to immunoregulatory, inflammatory, and host defense processes such as Cxcl2, Il6, Il11, Csf3r, Csf2, Ifna, Il1a, and Il1r2. Indeed, Wallerian degeneration has been thought of as an innate-immune response to external injuries (Rotshenker, 2011). Our outcomes demonstrate that immune reactions and inflammatory responses are initiated at an acute phase post-nerve injury, and suggest that innate immune and inflammatory responses in Wallerian degeneration might be critical for successful nerve regeneration and functional reconstitution. The KEGG pathway, neuroactive ligand-receptor interaction, was significantly enriched at later time points (6 hours to 4 weeks post-nerve injury). Differentially expressed genes in this KEGG pathway are mainly neurotransmitter receptors (e.g., Drd, Htr, Ntsr, Ptger, Adora, Grm, and P2rx). It has been demonstrated that certain neurotransmitters can affect Wallerian degeneration, namely adenosine, guanosine, adenosine triphosphate, and adenosine (Press and Milbrandt, 2009; Shin et al., 2014). From the genetic aspect, our outcomes show that neurotransmitters and their receptors might be involved in Wallerian degeneration. The axon guidance signaling pathway was also investigated. We found that receptors of semaphorins (Met), ephrins (Epha), and netrins (Unc-5) are differentially expressed following sciatic nerve transection. Semaphorins, ephrins, and netrins are proteins highly related to axon guidance. They play chemotropic roles during axon growth and attract a growing axon to move towards or away from higher concentrated regions. Interestingly, Met and Epha show differential temporal expression patterns compared with Unc-5, suggesting their roles in axon guidance and nerve regeneration might be different. Further studies will be performed to clarify their specific effects. However, it is worth noting that although we obtained some knowledge of dynamic molecular changes and essential signaling pathways during Wallerian degeneration, it remains unclear which cell types mediate these dynamic changes. Schwann cells and macrophages are important cells in distal nerve stumps, and consequently these dynamic changes may occur in these cell types. In our future studies, single cell sequencing will be performed to further decipher temporal expression patterns of genes in each cell type, and the specific role of each cell type during Wallerian degeneration. Taken together, we systematically investigated significantly enriched KEGG pathways in distal nerve stumps following sciatic nerve transection, and identified critical KEGG pathways for peripheral nerve repair and regeneration. Our results may help elucidate critical genes, signaling pathways, and biological processes during Wallerian degeneration, and might contribute to identification of potential treatments for peripheral nerve repair and regeneration.
Table 1

List of significantly involved Kyoto Enrichment of Genes and Genomes at various time points during Wallerian degeneration identified by bioinformatic analysis

Table 2

Significant differentially expressed genes in cytokine-cytokine receptor interaction

Table 3

Significant differentially expressed genes in neuroactive ligand-receptor interaction

  23 in total

Review 1.  Wallerian degeneration, wld(s), and nmnat.

Authors:  Michael P Coleman; Marc R Freeman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 2.  Chapter 3: Histology of the peripheral nerve and changes occurring during nerve regeneration.

Authors:  Stefano Geuna; Stefania Raimondo; Giulia Ronchi; Federica Di Scipio; Pierluigi Tos; Krzysztof Czaja; Michele Fornaro
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

3.  Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons.

Authors:  Jonathan Gilley; Michael P Coleman
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

4.  Signal flow and pathways in response to early Wallerian degeneration after rat sciatic nerve injury.

Authors:  Meiyuan Li; Weimin Guo; Pingan Zhang; Huaiqin Li; Xiaosong Gu; Dengbing Yao
Journal:  Neurosci Lett       Date:  2013-01-14       Impact factor: 3.046

5.  Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons.

Authors:  A M Avellino; D Hart; A T Dailey; M MacKinnon; D Ellegala; M Kliot
Journal:  Exp Neurol       Date:  1995-12       Impact factor: 5.330

6.  Poor growth of Mammalian motor and sensory axons into intact proximal nerve stumps.

Authors:  M C Brown; E R Lunn; V H Perry
Journal:  Eur J Neurosci       Date:  1991       Impact factor: 3.386

7.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

8.  The purine nucleosides adenosine and guanosine delay axonal degeneration in vitro.

Authors:  Craig Press; Jeffrey Milbrandt
Journal:  J Neurochem       Date:  2009-02-20       Impact factor: 5.372

9.  Ingenuity Pathway Analysis of Gene Expression Profiles in Distal Nerve Stump following Nerve Injury: Insights into Wallerian Degeneration.

Authors:  Jun Yu; Xiaosong Gu; Sheng Yi
Journal:  Front Cell Neurosci       Date:  2016-12-06       Impact factor: 5.505

10.  Rescue of peripheral and CNS axon defects in mice lacking NMNAT2.

Authors:  Jonathan Gilley; Robert Adalbert; Gang Yu; Michael P Coleman
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

View more
  6 in total

1.  SIRT6 Negatively Regulates Schwann Cells Dedifferentiation via Targeting c-Jun During Wallerian Degeneration After Peripheral Nerve Injury.

Authors:  Ying Zou; Jiaqi Zhang; Jingmin Liu; Jiawei Xu; Lanya Fu; Xinrui Ma; Yizhou Xu; Shuyi Xu; Xianghai Wang; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2021-10-27       Impact factor: 5.590

2.  Transcriptome analysis of adherens junction pathway-related genes after peripheral nerve injury.

Authors:  Sheng Yi; Xing-Hui Wang; Ling-Yan Xing
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

3.  Systemic functional enrichment and ceRNA network identification following peripheral nerve injury.

Authors:  Tianmei Qian; Chunlin Fan; Qianyan Liu; Sheng Yi
Journal:  Mol Brain       Date:  2018-12-17       Impact factor: 4.041

Review 4.  Pathophysiological Changes of Physical Barriers of Peripheral Nerves After Injury.

Authors:  Qianyan Liu; Xinghui Wang; Sheng Yi
Journal:  Front Neurosci       Date:  2018-08-23       Impact factor: 4.677

5.  Differential gene and protein expression between rat tibial nerve and common peroneal nerve during Wallerian degeneration.

Authors:  Yao-Fa Lin; Zheng Xie; Jun Zhou; Gang Yin; Hao-Dong Lin
Journal:  Neural Regen Res       Date:  2019-12       Impact factor: 5.135

6.  Schwann cell reprogramming and lung cancer progression: a meta-analysis of transcriptome data.

Authors:  Victor Menezes Silva; Jessica Alves Gomes; Liliane Patrícia Gonçalves Tenório; Genilda Castro de Omena Neta; Karen da Costa Paixão; Ana Kelly Fernandes Duarte; Gabriel Cerqueira Braz da Silva; Ricardo Jansen Santos Ferreira; Bruna Del Vechio Koike; Carolinne de Sales Marques; Rafael Danyllo da Silva Miguel; Aline Cavalcanti de Queiroz; Luciana Xavier Pereira; Carlos Alberto de Carvalho Fraga
Journal:  Oncotarget       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.